Search

 » Investigators in the Costa Rica HPV Vaccine Trial (CVT) Group

STUDIES DONE

Investigators in the Costa Rica HPV Vaccine Trial (CVT) Group

Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica—Bernal Cortés (specimen and repository manager), Paula González (LTFU: co-principal investigator), Rolando Herrero (CVT: co-principal investigator), Silvia E. Jiménez (trial coordinator), Carolina Porras (co-investigator), Ana Cecilia Rodríguez (co-investigator).


United States National Cancer Institute, Bethesda, MD, USA—Allan Hildesheim (co-principal investigator & NCI co-project officer), Aimée R. Kreimer (LTFU: co-principal investigator & NCI co-project officer), Douglas R. Lowy (HPV virologist), Mark Schiffman (CVT: medical monitor & NCI co-project officer), John T. Schiller (HPV virologist), Mark Sherman (CVT: QC pathologist), Sholom Wacholder (statistician).


Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA (HPV Immunology Laboratory)—Ligia A. Pinto, Troy J. Kemp


Georgetown University, Washington, DC, USA—Mary K. Sidawy (CVT: histopathologist)


DDL Diagnostic Laboratory, Netherlands (HPV DNA Testing)—Wim Quint, Leen—Jan van Doorn, Linda Struijk.


University of California, San Francisco, CA, USA—Joel M. Palefsky (expert on anal HPV infection and disease diagnosis and management), Teresa M. Darragh (pathologist and clinical management)


University of Virginia, Charlottesville, VA, USA—Mark H. Stoler (QC pathologist)

Back